Identification of therapeutic targets for chronic kidney disease through Mendelian randomization analysis of druggable genes
Abstract Chronic Kidney Disease (CKD) is a multifaceted and gradually advancing condition characterized by a complex pathogenesis. The current therapeutic options for CKD remain limited in efficacy. Consequently, the identification and exploration of novel drug targets for CKD are of paramount impor...
Saved in:
| Main Authors: | Run-Sen Liang, Jin-Qi Su, Xiang-Qi Wu, Qi Wang, Yong-Mei Cai, Hong-Yong Su, Ji-Xin Tang, Cui-Wei Yao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-94761-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of Potential Drug Targets for Immunoglobulin A Nephropathy: A Mendelian Randomization Study
by: Limei Xiong, et al.
Published: (2025-02-01) -
The Druggable Target Potential of NF-κB-Inducing Kinase (NIK) in Cancer
by: Yina Wang, et al.
Published: (2024-12-01) -
Deciphering CAP1 of Candida albicans as a key druggable target protein
by: Neha Jaiswal, et al.
Published: (2025-09-01) -
Causal association of metabolic syndrome with chronic kidney disease progression: A Mendelian randomization study
by: Qitong Guo, et al.
Published: (2024-12-01) -
Metabolomic Understanding of variable risk factors for kidney cancer: a two-sample Mendelian randomization study
by: Yihao Zhu, et al.
Published: (2025-07-01)